Total raised
—
Last: Seed 2020-05
Stage
Seed
Founded
2019
Headcount
1-10
HQ
Sector
Health Tech & Life Sciences
About
JAMM Therapeutics is a drug discovery company developing a novel treatment approach for systemic lupus erythematosus. The company is currently being established at the FutuRx biotech incubator.
Funding history · 1 round · — total
2020-05
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of JAMM Therapeutics?
- JAMM Therapeutics is a drug discovery company focused on developing a novel treatment approach for systemic lupus erythematosus.
- When was JAMM Therapeutics founded?
- JAMM Therapeutics was founded in October 2019.
- What is the current operational status of JAMM Therapeutics?
- JAMM Therapeutics is currently inactive, having ceased operations in July 2024.
- Where is JAMM Therapeutics headquartered?
- JAMM Therapeutics is headquartered in Ness Ziona, Israel, at Ilan Ramon Street 2.
- Which incubator was JAMM Therapeutics established at?
- JAMM Therapeutics was established at the FutuRx biotech incubator.
- When did JAMM Therapeutics complete its last known funding round?
- JAMM Therapeutics completed a Seed funding round in May 2020.
- Which investors participated in JAMM Therapeutics' Seed round?
- The Seed round for JAMM Therapeutics included investments from FutuRx and RMGP Biopharma Investment Fund.
- What is the employee count for JAMM Therapeutics?
- JAMM Therapeutics has an estimated employee count in the 1-10 range.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
drug-discoverypharmaceuticalsautoimmune-diseases